RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vivo Bio Tech Stock

Vivo Bio Tech Equity 2025

Vivo Bio Tech Equity

779.04 M INR

Ticker

511509.BO

ISIN

INE380K01017

In 2025, Vivo Bio Tech's equity was 779.04 M INR, a 50.18% increase from the 518.73 M INR equity in the previous year.

Vivo Bio Tech Aktienanalyse

What does Vivo Bio Tech do?

Vivo Bio Tech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Vivo Bio Tech's Equity

Vivo Bio Tech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Vivo Bio Tech's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Vivo Bio Tech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Vivo Bio Tech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Vivo Bio Tech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Vivo Bio Tech stock

What is the equity of Vivo Bio Tech this year?

Vivo Bio Tech has equity of 779.04 M INR this year.

What was the equity of Vivo Bio Tech compared to the previous year?

The equity of Vivo Bio Tech has increased/decreased by 50.18% increased compared to the previous year.

What impact does a high equity have on investors of Vivo Bio Tech?

A high equity is advantageous for investors of Vivo Bio Tech as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Vivo Bio Tech?

A low equity can be a risk for investors of Vivo Bio Tech, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Vivo Bio Tech affect the company?

An increase in equity of Vivo Bio Tech can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Vivo Bio Tech affect the company?

A reduction in equity of Vivo Bio Tech can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Vivo Bio Tech?

Some factors that can affect the equity of Vivo Bio Tech include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Vivo Bio Tech so important for investors?

The equity of Vivo Bio Tech is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Vivo Bio Tech take to change the equity?

To change equity, Vivo Bio Tech can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Vivo Bio Tech pay?

Over the past 12 months, Vivo Bio Tech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Vivo Bio Tech is expected to pay a dividend of 0 INR.

What is the dividend yield of Vivo Bio Tech?

The current dividend yield of Vivo Bio Tech is .

When does Vivo Bio Tech pay dividends?

Vivo Bio Tech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Vivo Bio Tech?

Vivo Bio Tech paid dividends every year for the past 0 years.

What is the dividend of Vivo Bio Tech?

For the upcoming 12 months, dividends amounting to 0 INR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Vivo Bio Tech located?

Vivo Bio Tech is assigned to the '-' sector.

Wann musste ich die Aktien von Vivo Bio Tech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vivo Bio Tech from 8/15/2025 amounting to 0 INR, you needed to have the stock in your portfolio before the ex-date on 8/15/2025.

When did Vivo Bio Tech pay the last dividend?

The last dividend was paid out on 8/15/2025.

What was the dividend of Vivo Bio Tech in the year 2024?

In the year 2024, Vivo Bio Tech distributed 0 INR as dividends.

In which currency does Vivo Bio Tech pay out the dividend?

The dividends of Vivo Bio Tech are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Vivo Bio Tech

Our stock analysis for Vivo Bio Tech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vivo Bio Tech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.